Anti-IL-23 Reference Antibody (mirikizumab)
Reagent
Code: #140223
blur_circular Chemical Specifications
inventory_2
Storage & Handling
Storage
-20℃
description Product Description
Used in the treatment of moderate to severe ulcerative colitis and psoriasis by targeting and neutralizing interleukin-23 (IL-23), a key cytokine involved in inflammatory pathways. It helps reduce chronic inflammation and improve symptoms in patients who do not respond adequately to conventional therapies. Also utilized in clinical research as a reference standard for developing biosimilars and evaluating anti-IL-23 drug efficacy.
shopping_cart Available Sizes & Pricing
Cart
No products
Subtotal:
0.00
Total
0.00
THB